True availability and access to treatment for patients is what brings long-term value to the patients we serve, our employees, partners and shareholders. The capabilities that make this possible are our knowledge of biologics manufacturing and industrialisation, our in-house research and development competencies within protein characterisation, and our ability to provide access to treatments for rare-disease patients. We believe that our ability to partner and to pioneer with different stakeholders – and bring together all the opportunities that exist to facilitate effective and timely rare-disease therapy development – creates unique opportunities to add value to the rare-disease field.

 

 

Sobi's value creation